Nuwellis, Inc.
NUWE
Positions held
Your positionsNUWE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $2.46M | Enterprise value | -$1.25M | Trailing P/E | 0.00 | Forward P/E | -0.26 |
| PEG | — | Price / book | -0.19 | Beta | 0.09 | Dividend yield | 0.00% |
| Revenue growth | 14.1% | Earnings growth | — | Gross margin | 69.7% | Operating margin | -1.6% |
| Profit margin | -125.6% | ROE | — | ROA | -87.8% | Debt / equity | — |
| Current ratio | 1.97 | Free cash flow | -$11.44M | Analyst recommendation | none | Mean target | — |
| 52w high | $172.90 | 52w low | $0.67 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $2.0M | $2.4M | $2.4M | $2.2M | $1.7M |
| Op margin | -160.9% | -190.1% | -100.8% | -121.7% | -168.5% |
| Net income | -$4.8M | -$4.5M | -$2.4M | $0.5M | -$12.6M |
| Gross margin | 76.1% | 70.1% | 68.2% | 65.2% | 55.5% |
| Gross profit | $1.5M | $1.7M | $1.7M | $1.4M | $1.0M |
| Operating income | -$3.2M | -$4.6M | -$2.4M | -$2.7M | -$2.9M |
- Revenue -18% vs prior quarter ($2.0M vs $2.4M).
- Gross margin 76.1% (was 70.1% prior quarter).
- Operating margin expanded to -161%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $8.3M | $8.7M | $8.9M | $8.5M | — |
| Op margin | -134.3% | -125.7% | -198.9% | -201.0% | — |
| Net income | -$17.5M | -$11.2M | -$20.2M | -$14.5M | — |
| Gross margin | 62.0% | 64.9% | 56.2% | 55.7% | — |
| Gross profit | $5.1M | $5.7M | $5.0M | $4.8M | — |
| Operating income | -$11.1M | -$11.0M | -$17.6M | -$17.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-17 · Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
2026-09-16 · Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
2026-09-09 · Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
2026-08-25 · Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
2026-08-18 · Nuwellis Files to Resell 1.35 Million Shares From Warrant Exercises
2026-08-13 · Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...
2026-08-06 · Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer
Price (daily)
Full chart · RSI · MACD · patterns